First Eagle Investment Management
BIIB icon

First Eagle Investment Management’s Biogen BIIB Stock Holding History

First Eagle Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-500
Closed -$1.84M – 106
2019
Q3 		$1.84M Buy
+500
New +$116K 0.01% 104
2017
Q2 		– Sell
-1,000
Closed -$11.5M – 330
2017
Q1 		$11.5M Buy
+1,000
New +$283K 0.03% 151

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

First Eagle Investment Management's BIIB Position: Q3 2020 in Review

First Eagle Investment Management sold out of Biogen (BIIB) in Q3 2020, closing a stake of 57,300 shares — an estimated $15.3M sold.

First Eagle Investment Management first reported a position in BIIB in Q4 2015 and held it in 6 quarters. The position peaked at $143M in Q3 2016. 1,052 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • First Eagle Investment Management reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
  • First Eagle Investment Management sold 57,300 Biogen shares in Q3 2020, an estimated $15.3M.
  • First Eagle Investment Management first reported a position in Biogen in Q4 2015 and held it in 6 quarters.
  • First Eagle Investment Management's Biogen position peaked at $143M in Q3 2016.
  • 1,052 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on First Eagle Investment Management's 13F filing for Q3 2020, filed 10 Nov 2020.